All News

Rivaroxaban with or without aspirin was evaluated for the secondary prevention of cardiovascular outcomes

Long-term intravitreous injections of novel drug found safe and effective for chronic retinal or choroidal vascular diseases.

Last year, 14 out of 100 graduating pharmacy students reported not taking any loans. How?

Patients with ovarian cancer often face complex burdens that go beyond just medication.

Guidelines needed to determine the appropriate length of opioid treatment after common surgical procedures.

Only 38% of parents are very confident that school staff can help a student with a suspected mental health problem.

A synthetic particle awakens dormant HIV cells then knocks them out.

The grant from the National Multiple Sclerosis Society aims to support the development of a potential oral treatment for progressive forms of MS.

Ingrezza is a selective VMAT2 inhibitor that was the first FDA-approved product indicated to treat adults with tardive dyskinesia.

An oncoprotein produced by the human papillomavirus results in cells that proliferate and do not die.

Animas Corporation to cease operations and sale of insulin pumps.

A biochip may be able to detect HIV in a drop of blood and display the results within 10 seconds.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Your professional viability and professional growth are important. Be proactive, prepared, and stay ahead of the curve.

In October, we celebrate American Pharmacists Month.

Have you ever considered pursuing a PGY-2 pharmacy residency in psychiatry?

A 3-step process to compare pharmacy schools' prerequisites and set an application timeline.

Imagine you are blind. How do you tell one prescription bottle from the next?

It is currently the first and only extended-release, intra-articular injection available for OA.

The study found patients who were prescribed antibiotics for dental procedures tended to be older and more likely to receive clindamycin, an antibiotic that is associated with C diff infection.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at the top stories in pharmacy last week.

Employers may have the market power to demand transparency from pharmacy benefit managers.

Mastectomy rates increased after actress Angelia Jolie announced her procedure.

Top news from across the healthcare landscape.

Top news from across the healthcare landscape.

FDA officials have approved an 80-mg capsule strength of Neurocrine Biosciences’ valbenazine (Ingrezza) for the treatment of adults with tardive dyskinesia (TD), the company announced in a press release

Janssen is seeking FDA approval for its once-daily darunavir-based regimen for HIV.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.